









Markets
/
Stocks
/
nasdaq-nuwe
/

Nuwellis Inc

NUWE

3.750USD

-0.100-2.60%

Close 02/02, 16:00（ET）Quotes delayed by 15 min

5.12MMarket Cap

0.02P/E TTM



Nuwellis Inc

3.750

-0.100-2.60%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Nuwellis Inc

Currency: USD Updated: 2026-02-02

Key Insights

Nuwellis Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 126 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 11.00.In the medium term, the stock price is expected to trend up.Despite a strong stock market performance over the past month, the company shows weak fundamentals and technicals, which don't support the current strong trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Nuwellis Inc's Score

Industry at a Glance

Industry Ranking

126 / 206

Overall Ranking

351 / 4529

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Nuwellis Inc Highlights

StrengthsRisks

Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Growing

The company is in a growing phase, with the latest annual income totaling USD 8.74M.

Overvalued

The company’s latest PE is 0.02, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 134.31K shares, increasing 40.58% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 31.00 shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.99.

Analyst Rating

Based on 1 analysts

Hold

Current Rating

11.000

Target Price

+4890.93%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-02

The current financial score of Nuwellis Inc is 5.11, ranking 203 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 2.22M, representing a year-over-year decrease of 6.34%, while its net profit experienced a year-over-year decrease of 80.11%.

Score

Industry at a Glance

Previous score

5.11

Change



Financials

7.87

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

2.38

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

2.83

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

5.39

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.07

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Nuwellis Inc's Company Valuation

Currency: USD Updated: 2026-02-02

The current valuation score of Nuwellis Inc is 7.68, ranking 68 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 0.02, which is 385.80% below the recent high of 0.09 and 1693.18% above the recent low of -0.28.

Score

Industry at a Glance

Previous score

7.68

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 126/206

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-02

The current earnings forecast score of Nuwellis Inc is 6.00, ranking 171 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 11.00, with a high of 11.00 and a low of 11.00.

Score

Industry at a Glance

Previous score

6.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 1 analysts

Hold

Current Rating

11.000

Target Price

+4890.93%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Nuwellis Inc

NUWE

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-02

The current price momentum score of Nuwellis Inc is 5.14, ranking 179 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 5.29 and the support level at 2.07, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

5.25

Change

-0.11

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.470

Buy

RSI(14)

69.816

Neutral

STOCH(KDJ)(9,3,3)

65.214

Neutral

ATR(14)

0.663

High Vlolatility

CCI(14)

90.064

Neutral

Williams %R

33.849

Buy

TRIX(12,20)

2.348

Sell

StochRSI(14)

7.864

Sell

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

3.900

Sell

MA10

2.968

Buy

MA20

2.490

Buy

MA50

2.336

Buy

MA100

2.840

Buy

MA200

11.065

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-02

The current institutional shareholding score of Nuwellis Inc is 5.00, ranking 113 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 8.11%, representing a quarter-over-quarter increase of 300.19%. The largest institutional shareholder is The Vanguard, holding a total of 31.00 shares, representing 0.00% of shares outstanding, with 95.91% decrease in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Sabby Management, LLC

35.89K

+918.85%

DRW Securities, LLC

36.08K

Bigger Capital Funds, LP

5.69K

Citi Investment Research (US)

1.15K

Tower Research Capital LLC

1.03K

+680.30%

UBS Financial Services, Inc.

2.86K

+52.10%

Erb (John L)

803.00

SBI Securities Co., Ltd.

63.00

+3.28%

The Vanguard Group, Inc.

Star Investors

31.00

BofA Global Research (US)

5.00

+400.00%

Risk Assessment

Currency: USD Updated: 2026-02-02

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Nuwellis Inc is 1.92, ranking 171 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is -0.14. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.